外显子组测序
医学微生物学
免疫缺陷
原发性免疫缺陷
医学
外显子组
人类免疫缺陷病毒(HIV)
儿科
遗传学
生物
免疫学
突变
免疫系统
基因
作者
Baran Erman,Ümran Aba,Canberk İpşir,Damla Pehlivan,Caner Aytekin,Gökhan Cildir,Begüm Çiçek,Ceren Bozkurt,Sidem Tekeoglu,Melisa Kaya,Cigdem Aydogmus,Funda Cipe,Gulsan Sucak,Sevgi Bilgic Eltan,Ahmet Özen,Safa Barıs,Elif Karakoç-Aydıner,Ayca Kıykım,Betül Karaatmaca,Hülya Köse
标识
DOI:10.1007/s10875-024-01759-w
摘要
Molecular diagnosis of inborn errors of immunity (IEI) plays a critical role in determining patients' long-term prognosis, treatment options, and genetic counseling. Over the past decade, the broader utilization of next-generation sequencing (NGS) techniques in both research and clinical settings has facilitated the evaluation of a significant proportion of patients for gene variants associated with IEI. In addition to its role in diagnosing known gene defects, the application of high-throughput techniques such as targeted, exome, and genome sequencing has led to the identification of novel disease-causing genes. However, the results obtained from these different methods can vary depending on disease phenotypes or patient characteristics. In this study, we conducted whole-exome sequencing (WES) in a sizable cohort of IEI patients, consisting of 303 individuals from 21 different clinical immunology centers in Türkiye. Our analysis resulted in likely genetic diagnoses for 41.1% of the patients (122 out of 297), revealing 52 novel variants and uncovering potential new IEI genes in six patients. The significance of understanding outcomes across various IEI cohorts cannot be overstated, and we believe that our findings will make a valuable contribution to the existing literature and foster collaborative research between clinicians and basic science researchers.
科研通智能强力驱动
Strongly Powered by AbleSci AI